Katie Kurtz
Medical · Conyers, GANPI 1124449723
Payments from drug & device makers
Across 145 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$504
- AstraZeneca$333
- Novo Nordisk$307
- Otsuka America Pharmaceutical, Inc.$277
- Pfizer$261
- Astellas Pharma US Inc$158
- plus $936 from 17 others
What the payments were for
- Food & beverage$2,777100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $504 |
| AstraZeneca | 20 | $333 |
| Novo Nordisk | 18 | $307 |
| Otsuka America Pharmaceutical, Inc. | 13 | $277 |
| Pfizer | 12 | $261 |
| Astellas Pharma US Inc | 6 | $158 |
| Exact Sciences | 9 | $156 |
| Boehringer Ingelheim | 8 | $133 |
| Bayer | 5 | $103 |
| GSK | 5 | $98 |
| Shield Therapeutics Inc | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Merck | 3 | $46 |
| Lundbeck LLC | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $31 |
| Amgen | 2 | $30 |
| Johnson & Johnson | 1 | $26 |
| AbbVie | 1 | $17 |
| Novartis | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$2,777 in reported general payments places this provider in the 70th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 58 | $83,918 |
| OzempicSemaglutide | 45 | $62,261 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 13 | $60,112 |
| RybelsusSemaglutide | 16 | $37,031 |
| JanuviaSitagliptin Phosphate | 26 | $32,302 |
| TrulicityDulaglutide | 21 | $27,297 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $24,204 |
| JardianceEmpagliflozin | 15 | $24,172 |
| FarxigaDapagliflozin Propanediol | 12 | $17,139 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $14,416 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $11,151 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $7,339 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $3,790 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $2,391 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 85 | $1,942 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $504 | $111,21579 claims |
| Novo NordiskOzempic, Rybelsus | $307 | $99,29261 claims |
| MerckJanuvia | $46 | $32,30226 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $333 | $31,55529 claims |
| Boehringer IngelheimJardiance | $133 | $24,17215 claims |
| GSKBreo Ellipta | $98 | $11,15120 claims |
| AbbVieSynthroid | $17 | $1,08312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 950 medical providers in Georgia.
Other medical in Conyers
- Katherine SimmonConyers$12K
- Ryan HoodConyers$11K
- Kaitlyn SmithConyers$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.